Alison Schneider, MD, is a gastroenterologist at the Cleveland Clinic Florida - Weston.
GI & Endoscopy
Pfizer and Exact Sciences teamed up to co-promote Cologuard through 2021.
While fecal microbiota transplantation improves microbial diversity in irritable bowel syndrome patients, it does not improve symptoms, according to a study published in Gut.
The American Cancer Society lowered the recommended age to begin screening for colorectal cancer from 50 to 45, but Samir Gupta, MD, of UC San Diego Health, said the updated guideline should be implemented cautiously.
When Scott Wilson took his first colorectal cancer test in his mid-40s, it was negative. Several years later, he was diagnosed with stage 4 colon cancer that physicians believed he had for half a decade. Now, he's trying to make…
Exact Sciences' colon cancer screening test, Cologuard, is polarizing. The test's noninvasive nature makes it a popular alternative for colonoscopy-fearing patients, but gastroenterologists are conflicted.
Michael Thomas is joining devicemaker Lumendi as vice president of sales.
The National Resident Matching Program reported more physicians matched for medical fellowships in 2018 than any year before, according to the American Medical Association.
Joseph F. Hacker III, MD, is a gastroenterologist at Newark-based Delaware Gastroenterology Associates.
Research presented at 2018 Digestive Disease Week, July 2 to July 5 in Washington, D.C., found authors of clinical practice guidelines for inflammatory bowel disease often have financial conflicts of interest, Gastroenterology & Endoscopy News reported.
